“Lung disease is the third biggest cause of death in the UK ... exacerbation or ‘flare up’ and will require extra treatment ...

COPD is a serious yet preventable disease, and early intervention can preserve lung function and overall well-being.

Although no cause of death or further details were given, the news comes months after Lynch announced he had been living with ...

The growing prevalence of COPD among women can be attributed to a combination of biological, environmental, and societal ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

Conclusion. In the treatment of COPD exacerbations, systemic corticosteroids improve airflow limitations, decrease treatment failure rates, decrease the risk of relapse, and may improve symptoms ...

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.